Heres Why Were Watching Adverum Biotechnologies Cash Burn Situation

ADVM Stock  USD 5.72  0.21  3.54%   
About 62% of Adverum Biotechnologies' investor base is looking to short. The analysis of the overall investor sentiment regarding Adverum Biotechnologies suggests that many traders are alarmed. Adverum Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Adverum Biotechnologies. Many technical investors use Adverum Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Read at finance.yahoo.com
Yahoo News
  

Adverum Biotechnologies Fundamental Analysis

We analyze Adverum Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adverum Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adverum Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Adverum Biotechnologies is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Adverum Biotechnologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adverum Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics with similar companies.

Peers

Adverum Biotechnologies Related Equities

PASGPassage Bio   2.63   
0%
16.0%
ADAGAdagene   0.47   
2.0%
0%
AVTEAerovate Therapeutics   1.14   
7.0%
0%
KZRKezar Life   1.60   
10.0%
0%
GLMDGalmed Pharmaceuticals   2.08   
13.0%
0%
MGTXMeiraGTx Holdings   2.28   
14.0%
0%
RYTMRhythm Pharmaceuticals   2.57   
16.0%
0%
MREOMereo BioPharma   3.12   
19.0%
0%
AFMDAffimed NV   3.54   
22.0%
0%
QUREUniqure NV   3.77   
23.0%
0%
ANTXAN2 Therapeutics   4.52   
28.0%
0%
STOKStoke Therapeutics   5.08   
31.0%
0%
ACRVAcrivon Therapeutics,   5.65   
35.0%
0%
RCKTRocket Pharmaceuticals   5.98   
37.0%
0%
RZLTRezolute   6.07   
37.0%
0%
KODKodiak Sciences   6.38   
39.0%
0%
SLDBSolid Biosciences   6.59   
41.0%
0%
ABSIAbsci Corp   15.98   
100.0%
0%
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Adverum Biotechnologies Hype Analysis, Adverum Biotechnologies Correlation and Adverum Biotechnologies Performance.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.